Global Lilly Oncology Young Investigator Meeting 2001Pharmacogenomic Research Award / Modulation of Effectiveness of Combined Gemcitabine-Radiation Therapy in the Management of Hormone Refractory Prostate Cancer by Restoring TNF-Alpha Sensitivity through Nuclear Factor-kappa B (NF-kB) Inhibition

Şengöz K. M.

Asco, Şubat 2001

• Ödülü Veren Organizasyon: Asco
• Ödülün Tarihi: Şubat 2001